Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Oxilan Generic Name & Formulations
Legal Class
Rx
General Description
Ioxilan 300mgI/mL, 350mgI/mL; soln for IV inj; preservative-free.
Pharmacological Class
Nonionic contrast agent.
How Supplied
Single-dose bottles (50mL, 100mL, 150mL, 200mL)—10
Manufacturer
Oxilan Indications
Indications
Intraarterial: For cerebral arteriography (300mgI/mL). For coronary arteriography and left ventriculography, visceral angiography, aortography, and peripheral arteriography (350mgI/mL). IV: For excretory urography and contrast enhanced computed tomographic (CECT) imaging of the head and body (300mgI/mL and 350mgI/mL).
Oxilan Dosage and Administration
Adult
Individualize. Intraarterial procedures: Left and right coronary: 2–10mL. Left ventricle: 25–50mL. Aortography and selective visceral: see literature. Aortic bifurcation for distal runoff: 45–100mL. Subclavian or femoral artery: 10–40mL. Total dose for procedure should not exceed 250mL. Cerebral arteriography: 8–12mL; total dose for procedure should not exceed 150mL. IV procedures: Excretory urography: 250–390mgI/kg; total dose for procedure should not exceed 100mL. CECT of the head: 100–200mL (300mgI/mL) or 86–172mL (350mgI/mL); total dose for procedure should not exceed 200mL. CECT of body: 50–200mL (300mgI/mL) or 43–172mL (350mgI/mL); total dose for procedure should not exceed 200mL.
Children
Not recommended.
Oxilan Contraindications
Contraindications
Intrathecal use.
Oxilan Boxed Warnings
Not Applicable
Oxilan Warnings/Precautions
Warnings/Precautions
Should be administered by professional trained in use of radiopaque agents in appropriate facilities with emergency treatment readily available. Homocystinuria: avoid. Severe renal impairment. Combined renal and hepatic disease. Combined renal and cardiac disease. CHF. Diabetes. Severe thyrotoxicosis. Myelomatosis. Anuria. Pheochromocytoma. Homozygous sickle cell disease. Immune disorders. Maintain adequate hydration. History of sever cutaneous hypersensitivity reaction; avoid. Avoid extravasation. Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
Oxilan Pharmacokinetics
See Literature
Oxilan Interactions
Interactions
Recently received cholecystographic agents in patients with hepatic or biliary disorder; increased risk of renal toxicity. Do not mix with other drugs. Radioactive iodine uptake studies may not accurately reflect thyroid function for up to 16 days.
Oxilan Adverse Reactions
Adverse Reactions
Headache, fever, hematoma at inj site, chills, angina, hypertension, bradycardia, hypotension, GI upset, dizziness, urticaria, rash; thromboembolic events, hypersensitivity reactions, severe cutaneous reactions (eg, SJS/TEN, AGEP, DRESS).
Oxilan Clinical Trials
See Literature
Oxilan Note
Not Applicable
Oxilan Patient Counseling
See Literature
